Susan Olalekan

989 total citations
10 papers, 344 citations indexed

About

Susan Olalekan is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Susan Olalekan has authored 10 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Susan Olalekan's work include Single-cell and spatial transcriptomics (3 papers), T-cell and B-cell Immunology (3 papers) and Immune Cell Function and Interaction (3 papers). Susan Olalekan is often cited by papers focused on Single-cell and spatial transcriptomics (3 papers), T-cell and B-cell Immunology (3 papers) and Immune Cell Function and Interaction (3 papers). Susan Olalekan collaborates with scholars based in United States and Japan. Susan Olalekan's co-authors include Yanxia Cao, Alison Finnegan, Keith M. Hamel, Anindita Basu, Bingqing Xie, Heather Eckart, Julie Kim, Joanna E. Burdette, Teresa K. Woodruff and Spiro Getsios and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and European Journal of Immunology.

In The Last Decade

Susan Olalekan

9 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Olalekan United States 7 179 109 82 71 59 10 344
Abigail L. Sedlacek United States 11 268 1.5× 111 1.0× 191 2.3× 28 0.4× 58 1.0× 18 477
Naomi Ohtsuji Japan 11 99 0.6× 90 0.8× 69 0.8× 47 0.7× 42 0.7× 23 295
Marie‐Aude Le Frère‐Belda France 12 86 0.5× 73 0.7× 152 1.9× 60 0.8× 130 2.2× 31 482
Janneke S. Hoogstad‐van Evert Netherlands 11 278 1.6× 64 0.6× 207 2.5× 22 0.3× 63 1.1× 15 416
Hedda H. van Ravenswaay Claasen Netherlands 7 180 1.0× 127 1.2× 154 1.9× 43 0.6× 61 1.0× 10 401
Hiroyuki Ariga Japan 10 138 0.8× 113 1.0× 216 2.6× 37 0.5× 24 0.4× 25 429
Tzu‐Bou Hsieh Taiwan 10 134 0.7× 117 1.1× 32 0.4× 16 0.2× 84 1.4× 14 396
SHOJIRO YANO Japan 11 98 0.5× 123 1.1× 77 0.9× 59 0.8× 48 0.8× 32 413
Mason Webb United States 12 127 0.7× 120 1.1× 193 2.4× 44 0.6× 50 0.8× 41 456
Yasunori Hashiguchi Japan 14 59 0.3× 236 2.2× 229 2.8× 80 1.1× 196 3.3× 37 549

Countries citing papers authored by Susan Olalekan

Since Specialization
Citations

This map shows the geographic impact of Susan Olalekan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Olalekan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Olalekan more than expected).

Fields of papers citing papers by Susan Olalekan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Olalekan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Olalekan. The network helps show where Susan Olalekan may publish in the future.

Co-authorship network of co-authors of Susan Olalekan

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Olalekan. A scholar is included among the top collaborators of Susan Olalekan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Olalekan. Susan Olalekan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Xie, Bingqing, et al.. (2024). Exploring the tumor micro-environment in primary and metastatic tumors of different ovarian cancer histotypes. Frontiers in Cell and Developmental Biology. 11. 1297219–1297219. 2 indexed citations
2.
Haltom, Amanda R., Janine Hensel, Jiha Kim, et al.. (2022). Engineered exosomes targeting MYC reverse the proneural-mesenchymal transition and extend survival of glioblastoma. SHILAP Revista de lepidopterología. 1. 100014–100014. 23 indexed citations
3.
Lengyel, Ernst, Yan Li, Melanie Weigert, et al.. (2022). A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing. Cell Reports. 41(12). 111838–111838. 29 indexed citations
4.
Olalekan, Susan, et al.. (2021). Characterizing the tumor microenvironment of metastatic ovarian cancer by single-cell transcriptomics. Cell Reports. 35(8). 109165–109165. 101 indexed citations
6.
Olalekan, Susan, Joanna E. Burdette, Spiro Getsios, Teresa K. Woodruff, & Julie Kim. (2017). Development of a novel human recellularized endometrium that responds to a 28-day hormone treatment†. Biology of Reproduction. 96(5). 971–981. 51 indexed citations
7.
Olalekan, Susan, Yanxia Cao, Keith M. Hamel, & Alison Finnegan. (2015). B cells expressing IFN‐γ suppress Treg‐cell differentiation and promote autoimmune experimental arthritis. European Journal of Immunology. 45(4). 988–998. 84 indexed citations
8.
Olalekan, Susan, Yanxia Cao, & Alison Finnegan. (2014). Tissue specific CD4+ T cell priming determines the requirement for interleukin-23 in experimental arthritis. Arthritis Research & Therapy. 16(5). 440–440. 4 indexed citations
9.
Cao, Yanxia, et al.. (2013). Location of CD4+ T Cell Priming Regulates the Differentiation of Th1 and Th17 Cells and Their Contribution to Arthritis. The Journal of Immunology. 190(11). 5423–5435. 26 indexed citations
10.
Hamel, Keith M., Yanxia Cao, Susan Olalekan, & Alison Finnegan. (2013). B Cell–Specific Expression of Inducible Costimulator Ligand Is Necessary for the Induction of Arthritis in Mice. Arthritis & Rheumatology. 66(1). 60–67. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026